drugset / Trial / NCT06962826

A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food

NCT06962826

Phase 1 Completed 14 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted to test how empagliflozin is taken up in the body when taken as a whole tablet or dissolved in water and mixed with food.

Timeline

Start
2025-05-27
Primary completion
2025-06-26
Completion
2025-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule

Indications

No indication recorded.